570 related articles for article (PubMed ID: 32477270)
1. Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US.
Czepiel KS; Perez NP; Campoverde Reyes KJ; Sabharwal S; Stanford FC
Front Endocrinol (Lausanne); 2020; 11():290. PubMed ID: 32477270
[TBL] [Abstract][Full Text] [Related]
2. THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE.
Shibuya K; Ali KF; Ji X; Milinoivh A; Bauman J; Kattan MW; Pantalone KM; Burguera B
Endocr Pract; 2019 Oct; 25(10):1022-1028. PubMed ID: 31241358
[No Abstract] [Full Text] [Related]
3. Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults.
Bensignor MO; Kelly AS; Arslanian S
Front Endocrinol (Lausanne); 2022; 13():1043650. PubMed ID: 36387846
[TBL] [Abstract][Full Text] [Related]
4. Obesity Management in Adults: A Review.
Elmaleh-Sachs A; Schwartz JL; Bramante CT; Nicklas JM; Gudzune KA; Jay M
JAMA; 2023 Nov; 330(20):2000-2015. PubMed ID: 38015216
[TBL] [Abstract][Full Text] [Related]
5. Five-year Weight Loss Maintenance With Obesity Pharmacotherapy.
Weintraub MA; D'Angelo D; Tchang BG; Sahagun AD; Andre C; Aronne LJ; Shukla AP
J Clin Endocrinol Metab; 2023 Aug; 108(9):e832-e841. PubMed ID: 36810608
[TBL] [Abstract][Full Text] [Related]
6. Real-world primary nonadherence to antiobesity medications.
Kan H; Bae JP; Dunn JP; Buysman EK; Gronroos NN; Swindle JP; Bengtson LGS; Ahmad N
J Manag Care Spec Pharm; 2023 Oct; 29(10):1099-1108. PubMed ID: 37594848
[No Abstract] [Full Text] [Related]
7. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
Gadde KM; Allison DB; Ryan DH; Peterson CA; Troupin B; Schwiers ML; Day WW
Lancet; 2011 Apr; 377(9774):1341-52. PubMed ID: 21481449
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice.
Song JE; Ko HJ; Kim AS
Drug Des Devel Ther; 2024; 18():845-858. PubMed ID: 38524878
[TBL] [Abstract][Full Text] [Related]
9. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
[No Abstract] [Full Text] [Related]
10. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial.
Pantalone KM; Smolarz BG; Ramasamy A; Baz Hecht M; Harty BJ; Rogen B; Griebeler ML; Borukh E; Young JB; Burguera B
JAMA Netw Open; 2021 Jul; 4(7):e2116595. PubMed ID: 34255049
[TBL] [Abstract][Full Text] [Related]
12. Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management.
Garvey WT
Expert Opin Drug Saf; 2013 Sep; 12(5):741-56. PubMed ID: 23738843
[TBL] [Abstract][Full Text] [Related]
13. Antiobesity Medication Use Among Overweight and Obese Adults in the United States: 2015-2018.
MacEwan J; Kan H; Chiu K; Poon JL; Shinde S; Ahmad NN
Endocr Pract; 2021 Nov; 27(11):1139-1148. PubMed ID: 34265455
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness and predictors of response to topiramate plus lifestyle modification in youth with obesity seen in a weight management clinical setting.
Bomberg EM; Clark J; Rudser KD; Gross AC; Kelly AS; Fox CK
Front Endocrinol (Lausanne); 2024; 15():1369270. PubMed ID: 38800488
[TBL] [Abstract][Full Text] [Related]
15. [The pharmacotherapy of obesity].
Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
[TBL] [Abstract][Full Text] [Related]
16. Current and future pharmacotherapies for obesity in children and adolescents.
Kelly AS
Nat Rev Endocrinol; 2023 Sep; 19(9):534-541. PubMed ID: 37337008
[TBL] [Abstract][Full Text] [Related]
17. Use of medications associated with weight change among participants in the All of Us research programme.
Almazan E; Schwartz JL; Gudzune KA
Clin Obes; 2023 Oct; 13(5):e12609. PubMed ID: 37455380
[TBL] [Abstract][Full Text] [Related]
18. Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options.
Cannon CP; Kumar A
Clin Cornerstone; 2009; 9(4):55-68; discussion 69-71. PubMed ID: 19789064
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
